Daniel Bergman, PhD

Dr. Bergman develops agent-based and mathematical models to investigate tumor-immune dynamics at the cell and tissue scale. His research integrates multiomics data to ground simulations in biological reality, with the goal of informing therapeutic interventions and advancing precision oncology.